Research Article
A Redox-Sensitive Micelle-Like Nanoparticle Self-Assembled from Amphiphilic Adriamycin-Human Serum Albumin Conjugates for Tumor Targeted Therapy
Figure 3
The in vitro drug release profile of HSA-ADR measured at different reducing agent GSH concentrations.